Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced TH17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome
✍ Scribed by Renner, Ellen D.; Rylaarsdam, Stacey; Aňover-Sombke, Stephanie; Rack, Anita L.; Reichenbach, Janine; Carey, John C.; Zhu, Qili; Jansson, Annette F.; Barboza, Julia; Schimke, Lena F.; Leppert, Mark F.; Getz, Melissa M.; Seger, Reinhard A.; Hill, Harry R.; Belohradsky, Bernd H.; Torgerson, Troy R.; Ochs, Hans D.
- Book ID
- 119280808
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 561 KB
- Volume
- 122
- Category
- Article
- ISSN
- 1097-6825
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Stat3 expression in cancer may have important prognostic and therapeutic value, but there has been no reports correlating Stat3 expression with prognosis in patients with osteosarcoma. The goal of this study is to correlate patient prognosis with the expression of Stat3 in osteosarcoma